|Podcasts|June 29, 2021

Infectious Pathogen Detection and Surveillance with Madhu Jasti

Infectious disease surveillance from wastewater and fecal samples has been recently adopted as a method for monitoring emergence and re-emergence of infectious diseases. This method allows public health agencies, universities, hospitals, cruise lines, and more to detect a pathogen and respond before there is a community outbreak. Thermo Fisher Scientific has partnered with many labs globally to implement new wastewater testing systems and optimization of existing wastewater monitoring processes. Listen in to learn about importance of wastewater.


To learn more about wastewater detection and surveillance, visit thermofisher.com/wastewatersurveillance


Related to this article

The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
Boehringer Ingelheim licenses six preclinical ADC and T-cell engager programs from Sino Biopharmaceutical in a deal worth up to $7 billion, Spyre Therapeutics drops anti-TL1A antibody SPY072 in rheumatic diseases after phase 2 misses and turns to hidradenitis suppurativa, and Biora Therapeutics gets ethics approval for a first-in-human trial of its BioJet oral adalimumab capsule.
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.